G protein Coupled Receptor (GPCR) signal transduction pathways in the striatum, a major reward- processing nucleus in the brain, play a pivotal role in the development of drug addiction. Many drugs of abuse including opioids and psychostimulants produce their effects by activating GPCRs expressed by striatal neurons. Our long-term goal is to elucidate molecular and cellular mechanisms that regulate signaling of the striatal GPCRs as a necessary prerequisite to understanding events that lead to substance dependence and designing strategies for the therapeutic correction. Increasing evidence suggests that Regulators of G Protein Signaling (RGS) proteins play a crucial role in controlling GPCR pathways implicated in addiction. RGS proteins serve to curb G protein signaling and thus are optimally positioned to naturally counteract excessive activation of GPCRs by drugs of abuse. Small molecule therapeutics targeting RGS proteins are emerging as promising therapeutic strategies. However, the mechanisms of RGS action in regulation of striatal G protein pathways are poorly understood. This proposal is focused on delineating the molecular, cellular and behavioral mechanisms by which key striatal RGS protein: the R7-RGS complex regulates signaling in striatal neurons. During the previous period, we made substantial progress in understanding R7-RGS including solving its high-resolution structure, defining its G protein selectivity and identification of cAMP to be critical second messenger system involved in its effects. These observations relied on a host of innovative tools and approaches we developed to study striatal GPCR signaling with high degree of precision. Based on accumulated data we hypothesize that control of opioid and dopamine receptor signaling via G Protein Gao to the downstream cAMP producing effector, adenylate cyclase by allosterically regulated multi- subunit R7-RGS complexes critically shapes behavioral actions of addictive drugs. This hypothesis will be tested by pursuing three complementary Specific Aims that seek to (1) delineate functional role of RGS - Gao axis in controlling cAMP dynamics, (2) determine structure/functional mechanics of RGS complex organization and (3) probe behavioral and circuit relevance of RGS-Gao in controlling responses to opioids and psychostimulants. The strategy proposed to address these Aims will entail a synergistic combination of genetic, biochemical, and physiological approaches, exploiting the existence of a powerful array of reagents, animal models, and innovative assays that allow examining signaling changes in vivo.

Public Health Relevance

Drug addiction is a disorder of the brain that puts a heavy burden on the society. Studies proposed herein are aimed at understanding molecular mechanisms controlling the function of the neuronal signaling systems that mediate the effects of adictive drugs. It is anticipated that the results will facilitate the design of novel strategies for the treatment of drug addiction and neurological diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA036596-06
Application #
9811325
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Hillery, Paul
Project Start
2014-09-15
Project End
2024-06-30
Budget Start
2019-08-01
Budget End
2020-06-30
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Scripps Florida
Department
Type
DUNS #
148230662
City
Jupiter
State
FL
Country
United States
Zip Code
33458
Qutob, Nouar; Masuho, Ikuo; Alon, Michal et al. (2018) RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells. Sci Rep 8:653
Song, Chenghui; Anderson, Garret R; Sutton, Laurie P et al. (2018) Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum. J Neurosci 38:7120-7131
Patil, Dipak N; Rangarajan, Erumbi S; Novick, Scott J et al. (2018) Structural organization of a major neuronal G protein regulator, the RGS7-G?5-R7BP complex. Elife 7:
Marcott, Pamela F; Gong, Sheng; Donthamsetti, Prashant et al. (2018) Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens. Neuron 98:575-587.e4
Hauser, Alexander S; Chavali, Sreenivas; Masuho, Ikuo et al. (2018) Pharmacogenomics of GPCR Drug Targets. Cell 172:41-54.e19
Muntean, Brian S; Zucca, Stefano; MacMullen, Courtney M et al. (2018) Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits. Cell Rep 24:1081-1084
Muntean, Brian S; Zucca, Stefano; MacMullen, Courtney M et al. (2018) Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits. Cell Rep 22:255-268
Himmelreich, Sophie; Masuho, Ikuo; Berry, Jacob A et al. (2017) Dopamine Receptor DAMB Signals via Gq to Mediate Forgetting in Drosophila. Cell Rep 21:2074-2081
Sutton, Laurie P; Ostrovskaya, Olga; Dao, Maria et al. (2016) Regulator of G-Protein Signaling 7 Regulates Reward Behavior by Controlling Opioid Signaling in the Striatum. Biol Psychiatry 80:235-45
Shamseldin, Hanan E; Masuho, Ikuo; Alenizi, Ahmed et al. (2016) GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition. Genome Biol 17:195

Showing the most recent 10 out of 21 publications